Pharmacokinetics and Anti‐Inflammatory Effects of Intramuscular Betamethasone in Exercised Thoroughbred Horses
Journal of Veterinary Pharmacology and Therapeutics · 2026
DOI: 10.1111/jvp.70052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, 2026. Verfasst von Juliana Sullivan und 4 weiteren Autor:innen. Beteiligte Einrichtung: K.L Maddy Equine Analytical Chemistry Laboratory (Pharmacology Section), School of Veterinary Medicine, University of California, Davis, California, …. Hauptthemen laut MEDLINE: Betamethasone, Anti-Inflammatory Agents, Physical Conditioning, Animal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The pharmacokinetics and pharmacodynamics of betamethasone following intra‐articular administration to horses have been described; however, studies characterizing intramuscular administration are lacking. Twenty‐four horses received an intramuscular dose of 12 mg betamethasone sodium phosphate/betamethasone acetate. Blood and urine were collected at post administration for up to 408 h. Concentrations of betamethasone were determined using LC–MS/MS and pharmacokinetic parameters determined using a Population PK three‐compartment model. The duration of pharmacodynamic effects was assessed by measuring changes in cortisol and inflammatory biomarkers utilizing an ex vivo model. The C max , T max , and terminal half‐life of betamethasone were 6.43 ± 1.70 ng/mL, 0.75 (0.5–2.0 h; median and range), and 30.5 ± 20.4 h, respectively. Covariates were not found to have significant effects on the variability of pharmacokinetic parameters. Based on Monte Carlo simulations, for 1000 horses, a detection time of 23 days is recommended for concentrations to fall below the screening limit of 10 pg/mL in 99% of the population. Urine concentrations were above the limit of quantitation in 2/24 horses at 408 h. Suppression of cortisol lasted for 360 h. Effects on inflammatory biomarker production lasted for a prolonged period. An extended withdrawal time for intramuscular administration prior to competition is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- K.L Maddy Equine Analytical Chemistry Laboratory (Pharmacology Section), School of Veterinary Medicine, University of California, Davis, California, USA.
- School of Veterinary Medicine, University of California, Davis, California, USA.
- Department of Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis, California, USA.
- Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, California, USA.
ORCID-Profile: Heather K Knych
Zitieren
APA
Sullivan, J., Blea, J., McKemie, D. S., Kass, P. H., & Knych, H. K. (2026). Pharmacokinetics and Anti‐Inflammatory Effects of Intramuscular Betamethasone in Exercised Thoroughbred Horses. Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.70052
Vancouver
Sullivan J, Blea J, McKemie DS, Kass PH, Knych HK. Pharmacokinetics and Anti‐Inflammatory Effects of Intramuscular Betamethasone in Exercised Thoroughbred Horses. Journal of Veterinary Pharmacology and Therapeutics. 2026. doi:10.1111/jvp.70052
BibTeX
@article{Sullivan2026,
author = {Sullivan, Juliana and Blea, Jeff and McKemie, Daniel S and Kass, Philip H and Knych, Heather K},
title = {Pharmacokinetics and Anti‐Inflammatory Effects of Intramuscular Betamethasone in Exercised Thoroughbred Horses},
journal = {Journal of Veterinary Pharmacology and Therapeutics},
year = {2026},
doi = {10.1111/jvp.70052}
}
EUVIMED